Race-Specific Spirometry Equations Do Not Improve Models of Dyspnea and Quantitative Chest CT Phenotypes.

"Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: A. L. N. receives support from UCSD Academic Senate and UCSD Division of Social Sciences Research grants. A. A. D. declares speaker fees from Boehringer Ingelheim, outside of the submitted work. A. K. B. is funded by the National Institutes of Health (NIH) [Grants KL2TR002492 and UL1TR002494], unrelated to the current work. S. P. B. is supported by the NIH [Grants R01 HL151421 and NIH UH3HL155806], Nuvaira, and Sanofi; and has received royalties from Springer Humana and consulting fees from Boehringer Ingelheim, Sanofi/Regeneron, and IntegrityCE, unrelated to the current work. R. C. has been supported by grants from AstraZeneca, Regeneron, and Genentech; consulting fees from Regeneron, Genentech, Inogen, and Boehringer Ingelheim; and honoraria from GlaxoSmithKline, unrelated to current work. R. C. is also on the Board of Directors for the COPD Foundation and President of the Pulmonary Education and Research Foundation. None declared (B. B., E. A. R., A. W., A. L., C. R., G. K., K. A. Y., B. F., C. H., D. J. C.)."

"Funding/Support This work was supported by the National Heart, Lung, and Blood Institute [Grants U01 HL089897 and U01 HL089856]. The COPDGene study47 is also supported by the COPD Foundation through contributions made to an Industry Advisory Committee composed of AstraZeneca, Bayer Pharmaceuticals, Boehringer Ingelheim, Genentech, GlaxoSmithKline, Novartis, Pfizer, and Sunovion. A. L. N. is supported by a UCSD Academic Senate Grant and a UCSD Division of Social Sciences Research Grant."